SynBioBeta Podcast: How an artist becomes an investor and advisor to the world’s greatest technology companies

No items found.
by
|
September 10, 2019

Today John Cumbers talks with D.A. Wallach, recording artist and emerging tech investor. John will be talking to D.A. about his journey from performing artist to investor in emerging tech, how his unique background informs his investment thesis, and what opportunities he’s most excited about in synthetic biology these days.D.A. Wallach is a recording artist, songwriter, and investor. While an undergraduate at Harvard, he was discovered by Kanye West and Pharrell Williams. As a solo artist, D.A. is signed by Harvest Records, a subsidiary of Capitol Records, and he is the former artist-in-residence at Spotify, a company where he was an early investor. Beyond music, D.A. invests in and advises several start-up technology companies, including Synthego, Glypse Bio, Beam Therapeutics, SpaceX, Ripple. Forbes selected D.A. as one of its 30 Under 30, and Fast Company named him one of the 100 Most Creative People in Business. In 2015, he launched Inevitable Ventures, an investment partnership with multibillionaire Ron Burkle that supports radical entrepreneurs in areas including health care, life sciences, and financial technologies. He is also an advisor to The Dreamers Fund, a partnership with actor Will Smith.Connect with D.A.: @dawallachConnect with John: @johncumbersStay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:Twitter | LinkedIn | FacebookBe sure you make it to SynBioBeta 2019 this October 1-3! Click here for more information.

Listen & Subscribe

Apple Podcasts
Google Podcasts
Spotify
Stitcher
Tune In
Pocket Casts
RSS Feed

Listen to the podcast in the player below:

Related Articles

No items found.